COVID-19: Our series of regulatory legislation trackers for the Life Sciences & Healthcare industry

Written By

marc martens Module
Marc Martens

Partner
Belgium

As co-head of our International Life Sciences & Healthcare group and head of Bird & Bird's Regulatory, Public & Administrative Law group in Brussels, I provide cutting edge strategic and regulatory advice to our life sciences clients and represent them in litigation.

mark hilton module
Mark Hilton

Partner
UK

I am a partner in our international Intellectual Property Group and co-head of our International Life Sciences & Healthcare Group. I'm based in London.

sally shorthose module
Sally Shorthose

Partner
UK

As one of our firm's most experienced intellectual property partners, specialising in transactional IP matters, I offer a wealth of knowledge to businesses at the cutting edge of research, development and technology, in a variety of sectors for which IP is of prime importance.

COVID-19 presents an unprecedented challenge to the global life sciences industry. Members of our International Life Sciences & Healthcare team, lawyers who have a wealth of hands-on experience and strong relationships with regulatory bodies, have worked together to provide an update in the form of a Q&A for each of the countries we are located. This update aims to provide guidance on the responses of EU and Asia-Pac regulators in the areas of clinical trials, medical devices, market access, public procurement and compulsory licensing.

COVID-19: Legislation Tracker for Medical Devices, read here

COVID-19: Legislation Tracker for Clinical Trials, read here

COVID-19: Legislation Tracker for Public Procurement, read here
 
COVID-19: Legislation Tracker for State Use/Compulsory Licensing, read here

COVID-19: Legislation Tracker for Market Access
, read here
 

 

Latest insights

More Insights
Curiosity line pink background

Unlocking Section 444GA: When Courts Can Bless Share Transfers in a DoCA

Sep 02 2025

Read More
Curiosity line yellow background

Cleared for Penalties: Webjet’s Misleading Consumer Practices Don’t Fly with the Federal Court

Aug 15 2025

Read More
Curiosity line blue background

Hong Kong’s Clinics to Prepare for Licensing Regime

Aug 13 2025

Read More